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ABSTRACT (248/250 words) 
Study Objectives: To examine the association between sleep apnea and pregnancy 
outcomes in a large population-based cohort. 
Methods: Population-based cohort study using linked birth and hospital records was 
conducted in New South Wales, Australia. Participants were all women who gave birth in 
hospital from 2002 to 2012 (N=636,227). Sleep apnea in the year before pregnancy or 
during pregnancy was identified from hospital records. Outcomes of interest were 
gestational diabetes, pregnancy hypertension, planned delivery, caesarean section, 
preterm birth, perinatal death, 5-minute Apgar score, admission to neonatal intensive care 
or special care nursery, and infant size for gestational age. Maternal outcomes were 
identified using a combination of hospital and birth records. Infant outcomes came from 
the birth record. Modified Poisson regression models were used to examine associations 
between sleep apnea and each outcome taking into account maternal age, country of 
birth, socioeconomic disadvantage, smoking, obesity, parity, pre-existing diabetes and 
hypertension. 
Results: Sleep apnea was significantly associated with pregnancy hypertension (adjusted 
RR 1.68; 95% CI 1.40 – 2.07), planned delivery (1.15; 1.07 – 1.23), preterm birth (1.50; 
1.21 – 1.84), 5-minute Apgar <7 (1.60; 1.07 – 2.38), admission to neonatal intensive 
care/special care nursery (1.26; 1.11 – 1.44), large-for-gestational-age infants (1.27; 1.04 
– 1.55) but not with gestational diabetes (1.09; 0.82 – 1.46), caesarean section (1.06; 0.96 
– 1.17), perinatal death (1.73; 0.92 – 3.25), or small-for-gestational-age infants (0.81; 
0.61 – 1.08).  
Conclusions: Sleep apnea is associated with higher rates of obstetric complications and 
intervention, as well as preterm delivery. Future research should examine if these are 
independent of obstetric history. 
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BRIEF SUMMARY 
 
Current Knowledge/Study Rationale: The evidence for an impact of sleep apnea on 
pregnancy is limited by weak study designs with small clinical samples and poor 
measurement of sleep apnea. The aim of the current study was to examine if sleep apnea 
was prospectively associated with maternal and infant outcomes in a population-based 
cohort, with an indicator of clinically significant sleep apnea.  
 
Study Impact: The study provides evidence that sleep apnea increases risks for a number 
of pregnancy outcomes. The findings, together with the greater literature, suggest a large-
scale intervention study is needed to determine if treatment of sleep apnea can fully 
ameliorate these risks.  
 
Keywords (min 3, max 10): (1) sleep-disordered breathing, (2) pregnancy, (3) 
gestational diabetes, (4) pregnancy-induced hypertension, (5) caesarean section, (6) 
premature birth, (7) small for gestational age, (8) perinatal death, (9) record linkage, (10) 
cohort study 
 
Manuscript=4123 words, 2 tables, no figures.  
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INTRODUCTION 
Sleep apnea is characterised by pauses in breathing during sleep causing 
intermittent blood oxygen desaturation and repeated awakening during the night. Snoring, 
daytime sleepiness and poor daytime function are the main symptoms. Sleep apnea is 
found disproportionately in men, those of late middle age, and those who are 
overweight/obese 
1
. More recently however, sleep apnea has been observed to occur 
commonly in pregnant women 
2, 3
. While protected by their relative youth and gender, 
pregnant women are at increased risk for sleep apnea because of the weight gain and 
hormonal changes associated with pregnancy 
4
. Nasal congestion 
5
, narrowing of the 
upper airway 
6
, increased tongue size relative to the oral cavity 
7
, and enlarged neck 
circumference 
8
 during pregnancy are all believed to be contributing factors.  
In the general population, frank sleep apnea confers long-term risk for cognitive 
impairment 
9, 10
, hypertension 
11
, stroke 
12, 13
, and cardiovascular mortality 
13, 14
. In the 
pregnant population, sleep apnea has been linked to gestational diabetes 
2, 3, 15
, gestational 
hypertension, pre-eclampsia and eclampsia 
2, 3, 16
, low birthweight infants 
2, 3
, intrauterine 
growth restriction 
3
, and neonatal intensive care unit (NICU) admission 
3
. Despite a 
number of independent systematic reviews and meta-analyses 
2, 3, 15, 16
, conclusions about 
the impact of sleep apnea on pregnancy are limited by the quality of the primary studies, 
which have been mainly case-control or cross-sectional in nature. Most have involved 
small clinical samples susceptible to selection bias and with varying degrees of control 
for confounding. There are also a number of perplexing results which might be solved by 
larger and better designed studies. For instance, some studies report that sleep apnea is 
associated with low birthweight infants, while others report no difference in the mean 
birthweight of babies born to mothers with and without sleep apnea 
2, 3
. Still others show 
an association between maternal sleep apnea and NICU admission, but paradoxically 
sleep apnea does not appear related to preterm birth or Apgar scores of infant condition 
soon after birth which would indicate grounds for admission 
3
. Further, the majority of 
previous studies have used self-reported snoring as indicative of sleep-disordered 
breathing, even though snoring alone is a poor indicator of clinically significant sleep 
apnea 
17
. Thus the aim of the current study was to examine the association between sleep 
6 
apnea and maternal and infant outcomes in a population-based cohort, using routinely 
collected health records.  
 
METHODS 
 
Data sources 
New South Wales (NSW) is the most populous state in Australia and sees 
approximately 93,000 births each year, which equates to over 30% of all births in the 
country 
18
. Data for this study came from two sets of routinely collected health data: the 
NSW Perinatal Data Collection (birth records) 
19
 and the NSW Admitted Patient Data 
Collection (hospital records).  
The birth records describe all births in NSW of at least 20 weeks gestation or at 
least 400g weight. The birth information is collected by the attending midwife or medical 
practitioner and includes data on maternal health, pregnancy, labour, delivery, and infant 
characteristics. The hospital records are a census of discharges, transfers and deaths from 
NSW public and private hospitals and day procedure centres. Diagnoses and procedures 
associated with each hospital record are coded by trained medical coders according to the 
International Statistical Classification of Diseases and Related Health Problems, Tenth 
Revision, Australian Modification (ICD-10-AM) 
20
 and the Australian Classification of 
Health Interventions 
21
. Up to 20 diagnoses and 20 procedures associated with each 
admission can be coded, in addition to the principal diagnosis or primary procedure that 
is the reason for admission.  
The birth records and hospital records were linked by the NSW Centre for Health 
Record Linkage (http://www.cherel.org.au/) using probabilistic record linkage and 
ChoiceMaker software. Australia does not have a national system of unique individual 
identifiers so multiple personal identifiers and probabilistic record linkage is used. 
Probabilistic record linkage involves assigning weights to pairs of records based on the 
degree of matching on personal identifiers such as names, birth dates, and addresses. 
Highly-weighted pairs of records are considered matches and lowly weighted pairs are 
considered non-matches. Clerical review is conducted of middle-weighted pairs and the 
process is repeated until there are fewer than 5/1,000 false positives and fewer than 
7 
5/1,000 false negatives when identifiers are available
22
. The data custodians then remove 
identifiers to preserve privacy and provide a unique linkage key to researchers to link 
relevant records for study. 
Ethics approval came from the NSW Population and Health Services Research 
Ethics Committee. 
 
Study population and study period 
The study population were all women who gave birth during the period 1
st
 
January 2002 to 31
st
 December 2012. There were 636,227 unique women and 1,023,357 
babies. We selected only the first birth so that each woman appeared only once in the 
study population and only the first infant from multiple births were counted in the 
outcomes. We note that the first birth in the study period is not equivalent to a woman’s 
first delivery, as she may have birthed prior to 2002 and these births are not captured in 
our data. Parity was recorded and adjusted for in the analyses. Thus there were 636,227 
women and 636,227 infants in the study population.  
The beginning of the study period for each woman was calculated by subtracting 
365 days from the estimated date of conception and the end of the study period was 
demarcated by delivery. The date of conception was estimated by subtracting gestational 
age in completed weeks from the delivery date and adding 2 weeks (14 days).  
Hospital records were linked to the birth records and hospital admissions in the 
study period for each woman were used to identify the presence of sleep apnea and other 
medical conditions.  
 
Sleep apnea 
Sleep apnea was defined using the ICD-10-AM diagnosis code G47.3 “Sleep 
apnoea” which included subcategories of central and obstructive sleep apneas (G47.3x). 
Women with a sleep apnea code in hospital records in the year before or during 
pregnancy were considered to have sleep apnea while women without a sleep apnea code 
during this period were considered not to have sleep apnea. Previous validation of 
hospital records against medical record review has shown that conditions identified in 
this way have a specificity rate of over 99% 
23
.  
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Outcomes 
Outcomes for this study were gestational diabetes, pregnancy hypertension, 
planned delivery, caesarean section, preterm birth, 5-minute Apgar, admission to the 
neonatal intensive care unit (NICU) or special care nursery (SCN), perinatal death and 
infant size for gestational age. 
Gestational diabetes and pregnancy hypertension (including gestational 
hypertension, pre-eclampsia or eclampsia) were derived from a combination of hospital 
and birth record data which have been previously validated against medical records 
24, 25
.  
Information on the type of delivery and infant outcomes came from the birth records. 
Planned deliveries and caesarean sections were indicated by check box on the 
birth record. These outcomes have been shown to correspond well to the maternal 
medical record 
26
. Planned delivery refers to births without spontaneous labour i.e. those 
requiring induction of labour or caesarean section. Planned delivery indicates a birth 
required obstetric intervention and is therefore a marker of pregnancy complications. In 
this context it likely represents comorbidities with sufficient severity to prompt 
intervention.  
All of the infant outcomes were from the birth record. Preterm birth before 37 
completed weeks of gestation was determined from gestational age on the birth record, 
which in turn is based on the best clinical estimate of gestational age using a combination 
of early ultrasound and date of last menstrual period. Apgar score at 5 minutes was 
dichotomised into those considered normal (≥7) and those considered low (<7)27. 
Admission to the neonatal intensive care unit (NICU) or the special care nursery (SCN) 
was combined as changes to data collection over time meant the two could not be 
considered separately. Perinatal death comprised stillbirths and neonatal death up to 28 
days after birth. Small for gestational age (SGA) were infants smaller than the 10
th
 
percentile of birth weight for their gestational age and sex, and large for gestational age 
(LGA) were infants larger than 90
th
 percentile of birth weight for gestational age and sex 
28, 29
.  
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Covariates 
Information on maternal and pregnancy characteristics came from the birth record. These 
included maternal age (in years), country of birth (Australia/other), socioeconomic 
disadvantage (quintiles), smoking during pregnancy (any/none), parity 
(nulliparous/multiparous), and plurality (singleton/multiple). Socioeconomic 
disadvantage was defined by the Index of Relative Socio-Economic Disadvantage 
according to a woman’s residential postcode. The index is a standard composite measure 
created by the Australian Bureau of Statistics for each geographical area and takes into 
account the proportion of residents who have low income, no educational qualifications, 
are unemployed or employed in unskilled work, live in overcrowded or low rent housing, 
who have a disability, poor English, no access to a car, and who are in single parent 
households 
30
. Quintiles for socioeconomic disadvantage were calculated based on the 
entire population of women giving birth in New South Wales.  
Information on the maternal conditions of chronic hypertension and pre-existing 
diabetes were derived from a combination of hospital and birth records which have been 
previously validated against medical records 
24, 25
. Maternal morbid obesity was 
identified through hospital admissions records during the study period where an ICD-10-
AM code of E65 (localised adiposity) or E66 (obesity) was recorded. 
 
Statistical Analysis 
Characteristics of women with and without sleep apnea were compared using chi-
squared tests. Pregnancy outcomes were compared between women with sleep apnea and 
those without. Modified Poisson regression with robust error variance was used to 
estimate relative risks with 95% confidence intervals
31
. We chose to analyse the data 
using modified Poisson regression rather than logistic regression since this approach 
calculates relative risks directly and these are more easily interpreted than odds ratios. 
The odds ratios from logistic regression approximate relative risks when the outcome is 
rare, but the outcomes in this study are not uncommon so the relative risks would be 
overestimated if logistic regression was applied. Poisson regression is usually applied to 
count data, therefore the method has been ‘modified’ to more correctly estimate the 
standard errors for binary outcomes
31
.  
10 
The analyses for each outcome were performed with and without adjustment for 
the covariates of maternal age, country of birth, socioeconomic disadvantage, smoking, 
obesity, and parity. For gestational diabetes, only these covariates were included in the 
adjusted model. For pregnancy hypertension, we also controlled for the risk factors of 
chronic hypertension and pre-existing diabetes. For all other outcomes, we also included 
chronic hypertension, pregnancy hypertension, pre-existing diabetes, and gestational 
diabetes in the adjusted models.  
The diagnosis of gestational diabetes is only applied to women without pre-
existing diabetes, and hence it is not possible to control for pre-existing diabetes in the 
model for gestational diabetes. However, we also conducted a sensitivity analysis for 
gestational diabetes which excluded women with pre-existing diabetes.  
The models for preterm birth were further stratified by delivery onset 
(spontaneous labour vs. planned delivery) and the models for NICU/SCN admission were 
stratified by gestational age (preterm vs. term) to explore the reasons for the observed 
associations. 
All analyses were conducted using SAS 9.3 (SAS Institute, NC).  
 
RESULTS 
Of the 636,227 women who delivered in the study period, 519 (0.08%) had a 
hospital admission with diagnosis of sleep apnea before or during pregnancy. The 
characteristics of women with and without a hospital record for sleep apnea are presented 
in Table 1. Women with sleep apnea were older, more likely Australian-born, and more 
socioeconomically advantaged than those without sleep apnea. Women with sleep apnea 
also had higher rates of smoking, obesity, pre-existing diabetes, chronic hypertension, 
and more were in their first pregnancy compared to those without a diagnosis of sleep 
apnea.  
The associations between sleep apnea and the outcomes from the crude and fully-
adjusted models are presented in Table 2. In the crude models, women with sleep apnea 
were not more likely to have gestational diabetes than women without sleep apnea, nor 
were they more likely to have SGA infants. Sleep apnea was significantly associated with 
11 
the other outcomes, although these associations were attenuated when maternal 
demographics and health risk factors were included in the models.  
Sleep apnea remained significantly predictive of pregnancy hypertension, planned 
delivery, preterm birth, low Apgar5, NICU/SCN admission and LGA infants. The 
association between preterm birth and sleep apnea was driven by planned deliveries, 
while risk of NICU/SCN admissions was significantly increased only in term infants. 
Perinatal death was a rare outcome and although there appears to be a large elevated risk 
associated with sleep apnea, this was not statistically significant. 
When women with pre-existing diabetes were excluded, the result for gestational 
diabetes was unchanged, i.e. sleep apnea was not significantly associated with risk for 
gestational diabetes compared to no-apnea (RR 1.27; 0.91 – 1.78).  
 
DISCUSSION 
Our study found that a diagnosis of sleep apnea in hospital records in the year 
before or during pregnancy was associated with adverse pregnancy outcomes in a 
population-based cohort of women. Women with sleep apnea were more likely to have 
pregnancy hypertension compared to women without sleep apnea, but they were not more 
likely to have gestational diabetes. Sleep apnea was associated with increased risk of 
planned deliveries and preterm births even after taking into account hypertension, 
diabetes, and other key risk factors. The infants of women with sleep apnea were more 
likely to be large for gestational age and to be admitted to the NICU or SCN than those 
born to women without a diagnosis of sleep apnea. However, sleep apnea was not 
significantly associated with caesarean section, perinatal death or small-for-gestational 
age infants.  
Two previous studies have used population health data to examine the association 
between obstructive sleep apnea (OSA), the most common form of apnea, and pregnancy 
outcomes: Chen et al (2012) conducted a population-based case-control study using 
linked health insurance and birth register records in Taiwan 
32
 and Louis et al (2014) 
analysed nationally representative hospital delivery records in the United States 
33
. These 
studies and ours are qualitatively different to the studies that have been reviewed in meta-
12 
analyses on the topic 
2, 3, 15, 16
 and hence we will discuss the results with particular 
reference to these studies.  
We found no association between sleep apnea and gestational diabetes which was 
surprising given meta-analyses of clinical studies show a pooled odds ratio ranging from 
1.9 – 3.0 between sleep-disordered breathing and gestational diabetes 2, 3, 15. The two 
previous population-based studies also reported higher risk of gestational diabetes 
associated with OSA (ORs 1.6 and 1.9 respectively) despite reporting low rates of sleep 
apnea and controlling only for ICD code of obesity, as in the current study 
32, 33
. It is 
unclear what might account for this disparity, especially since gestational diabetes was 
not associated with sleep apnea in our population even before control for confounding. It 
may be the case that sleep apnea does not contribute independently to risk for gestational 
diabetes despite the two conditions being commonly comorbid. A meta-analysis by Ding 
and colleagues
3
 supports this view, as a significant association between sleep apnea and 
gestational diabetes was only found in non-prospective studies (pooled OR from 5 
studies: 2.11, 95% CI: 1.60 - 2.80), but the association was not significant for prospective 
studies (pooled OR 1.20, 95% CI: 0.93, 1.53). Another meta-analysis by Xu and 
colleagues 
16
 of cohort studies on the relationship between OSA and gestational diabetes 
reported a modest but non-significant increase in the risk for gestational diabetes (pooled 
RR 1.40; 95% CI: 0.62 - 3.19). This would be consistent with the finding that sleep apnea 
does not predict incident diabetes in the general population although diabetes does appear 
to predict subsequent sleep-disordered breathing 
34, 35
.  
In contrast, the observed association between sleep apnea and pregnancy 
hypertension is consistent with both clinical and population-based studies. These have 
shown sleep apnea is associated with a greater than two-fold odds ratio for pregnancy-
related hypertension, and a roughly two-fold odds ratio for pre-eclampsia 
2, 3, 32, 33
. Sleep 
apnea is similarly predictive of hypertension in the general population 
11
 and treatment of 
sleep apnea has demonstrated improvements in blood pressure 
11, 36
, which raises the 
question of whether treatment or prevention of sleep apnea may improve hypertensive 
disorders in pregnancy. Two small intervention studies have shown that continuous 
positive airway pressure improves blood pressure in pregnant women with pre-eclampsia 
13 
37, 38
, although impact on pregnancy outcomes were not examined and this will need to be 
addressed in future research. 
A novel finding in the present study was that sleep apnea was not significantly 
associated with perinatal death, although the risk was elevated. Previous clinical studies 
have been precluded from recruiting mothers with stillbirths due to ethical considerations. 
Louis and colleagues examined the association between OSA and stillbirth and found no 
significant association based on maternal delivery records 
33
. That study was able to take 
into account more maternal comorbidities than the present study, hence the increased risk 
seen here may be due to residual confounding by maternal cardiovascular, renal, or 
pulmonary disease. However, Louis and colleagues examined only stillbirths and not 
neonatal deaths, which are also included in perinatal mortality here. Given the rarity and 
gravity of the outcome, the association between sleep apnea and perinatal death warrants 
further study.  
An increase in preterm birth could be one reason for a tendency to more infant 
deaths. The increased risk for preterm births in mothers with sleep apnea observed in the 
current study is consistent with previous population and clinical studies 
3, 32, 33
. However, 
our subgroup analysis showed that the association is mainly driven by planned deliveries, 
suggesting that sleep apnea is linked to other complications that call for obstetric 
intervention, but does not increase the risk of spontaneous preterm delivery. We also 
found that sleep apnea was associated with a small increase in the risk for planned 
delivery, although this was not reflected in greater likelihood of any caesarean section. 
This is in contrast to a previous study from the US which showed caesarean section was 
more likely in mothers who snored 
39
 and those with diagnosed OSA 
33
.  
We observed an association between sleep apnea and admission to the 
NICU/SCN for term but not preterm babies. Preterm infants may be admitted to the 
NICU/SCN on the basis of prematurity alone, whilst it appears maternal sleep apnea 
increases the likelihood of NICU/SCN admission for term infants. In the current study, 
this is consistent with the tendency to lower Apgar scores for these infants, reflecting 
poorer condition of the baby soon after birth.  
Lastly, we found sleep apnea was associated with infants that were large, rather 
than small, for gestational age. This was unexpected as the intermittent hypoxia 
14 
associated with sleep apnea has been hypothesised to result in small infants 
40
 and in 
previous studies has been linked to low birthweight 
2, 3
 and intrauterine growth restriction 
3
. However, there are a number of studies that have found no difference in the average 
weight of infants born to mothers with and without sleep apnea 
2, 3
. We cannot discount 
the possibility that sleep apnea was associated with larger than expected infants due to 
residual confounding by obesity since we were only able to account for morbid obesity in 
the analyses. It is important to note however that the two previous population-based 
studies were similarly constrained in their ability to control for obesity but still reported 
an increased risk for small infants associated with OSA (ORs 1.2 and 1.3) 
32, 33
. These 
studies did not explore an association with large infants and our results require replication 
in a cohort able to control for pre-pregnancy BMI.  
 
Strengths and limitations 
Strengths of the present study include the use of linked datasets from a large and 
population-based sample of mothers and infants, the use of objective sleep apnea as the 
exposure, and validated information on the outcomes and risk factors. The evidence for 
the relationship between sleep apnea and maternal outcomes can be considered cross-
sectional associations, while associations between sleep apnea and the nature of delivery 
and infant outcomes are longitudinal, which provides stronger evidence for a causal link 
between sleep apnea and the outcomes than previous cross-sectionally or retrospectively 
collected data.  
Many previous studies investigating sleep apnea in pregnancy have been limited 
by selected samples, cross-sectional or case-control study designs, and reliance on self-
reported snoring as the main measure of sleep apnea. The present study was able to 
examine the associations between objective report of sleep apnea and outcomes for a 
population-based cohort of women and their infants, which has the advantages of a 
representative sample, large sample size, and the ability to control for multiple risk 
factors.  
Previous studies have relied heavily on self-reported snoring as an indicator of 
sleep-disordered breathing, although only a small subset of those who snore will have 
significant sleep apnea
41
. The use of sleep apnea diagnosis from hospital records as our 
15 
exposure therefore improves on previous studies. The hospital records have been shown 
to have high specificity (over 99%) for a range of medical conditions when compared to 
medical record review 
23
, meaning that the sleep apnea group likely contains true cases of 
clinically significant sleep-disordered breathing. This is further supported by our finding 
that 70% of those with sleep apnea had it as their principal diagnosis (and the reason for 
hospital or clinic admission) and 61% of those with sleep apnea also had a procedure 
code in the hospital records indicating they underwent a sleep test in the study period.  
We included all types of sleep apnea in the current study because the purported 
effects on pregnancy outcomes derive from symptoms common to both obstructive and 
central apneas i.e. pauses in breathing causing hypoxaemia. More practically, there is a 
lack of specificity in the medical coding of sleep apnea such that unspecified sleep apnea 
constitutes 79% of all cases in the current study, with 20% specified as obstructive and 
<1% specified as central (see Supplementary Table 1 for details).  
The rate of sleep apnea determined through hospital records was very low at 
0.08%, although studies based on health records in the Taiwan and the United States 
report similarly low rates (0.03% and 0.01% respectively) 
32, 33
. The hospital data likely 
underestimates the prevalence of sleep apnea in the study population. We assumed that 
women without a sleep apnea code in their hospital record did not have sleep apnea. 
Some of these women may have had sleep apnea that was (i) not recorded on their 
hospital records or (ii) not recorded because they were not admitted to hospital prior to or 
during the course of their pregnancy. However, the inclusion of women with 
unrecognized sleep apnea in the group with “no sleep apnea” should bias the results 
conservatively towards the null. 
We did not have information on the severity of sleep apnea to determine if more 
severe sleep apnea was correlated with worse pregnancy outcomes. Such information 
would be important to collect in future studies and would be strong evidence for a causal 
effect of sleep apnea on maternal and infant health.  
   A limitation of the current study is that we have no information on treatment of 
sleep apnea or compliance with treatment. It is likely that diagnosed sleep apnea in 
hospital records would be accompanied by treatment, although we have no way of 
determining the severity of the apnea, the provision of treatment, or the degree of 
16 
compliance with treatment. However, compliance with treatment would be expected to 
reduce any association between sleep apnea and pregnancy outcomes.  
We were able to control for a number of major confounding factors, including 
age, smoking, hypertension, diabetes, and socioeconomic status. In addition, the data on 
diabetes and hypertension diagnoses and delivery outcomes have been previously 
validated 
24-26
. However, we cannot rule out residual confounding, such as by obstetric 
history or obesity. Although we attempted to control for the effects of obesity by 
identifying mothers with a record of morbid obesity (BMI>30kgm
-2
), this was found in 
<1% of the sample compared to estimated total overweight/obesity rates of 18 - 52% in 
NSW women of reproductive age from health surveys 
43
.  
 
Implications and conclusions 
We found that sleep apnea was associated with pregnancy hypertension, planned 
delivery, preterm birth, 5-minute Apgar <7, admission to NICU/SCN, and large-for-
gestational-age infants. Although the results are not conclusive of a causal link, they 
show that women with sleep apnea are at increased risk of adverse outcomes and suggest 
it may be important to identify and manage sleep apnea in pregnancy, especially as other 
studies have shown sleep apnea symptoms become more common and increase in 
severity over the course of pregnancy.  
Future research should investigate if the associations between sleep apnea and 
pregnancy outcomes are independent of obesity and other obstetric risk factors, and if 
intervention for sleep apnea can reduce risk of adverse pregnancy outcomes.  
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Table 1. Demographic, health, and pregnancy characteristics of 636,227 pregnant women 
with and without sleep apnea. 
 Sleep apnea 
n=519 
(n, col%) 
No sleep apnea 
n=635,708 
(n, col%) 
Maternal age   
<20 years 57 (11.0) 32,086 (5.1) 
20-34 years 286 (55.1) 477,366 (75.1) 
35+years 176 (33.9) 126,071 (19.8) 
Born in Australia 430 (82.9) 426,821 (67.1) 
Disadvantage quintile (SEIFA)   
Most disadvantaged 77 (14.8) 117,799 (18.5) 
Disadvantaged 93 (17.9) 119,679 (18.8) 
Average 106 (20.4) 130,082 (20.5) 
Advantaged 129 (24.9) 124,155 (19.5) 
Most advantaged 114 (22.0) 135,132 (21.3) 
Smoking during pregnancy 70 (13.5) 80,414 (12.7) 
Morbid obesity  61 (11.8) 3,775 (0.6) 
Pre-existing diabetes  35 (6.7) 3,577 (0.6) 
Chronic hypertension  23 (4.4) 7,270 (1.1) 
Nulliparous 400 (77.1) 418,816 (65.9) 
Multiple pregnancy 9 (1.7) 9,942 (1.6) 
All differences between sleep apnea and no-apnea groups are statistically significant at p<0.01, with the 
exception of plurality (multiple pregnancy) where p=0.75. 
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Table 2. Comparison of maternal and infant outcomes in 636,227 pregnant women with 
and without sleep apnea.  
 
Sleep apnea 
n=519 
No sleep apnea 
n=635,261 
 
Outcome  (n, col%)  (n, col%) RR (95% CI) adjusted RR (95% 
CI) 
Gestational 
diabetes 
42 (8.1%) 39,559 (6.2%) 1.30 (0.97 – 1.74) 1.09 (0.82 – 1.46) 
Pregnancy 
hypertension  
102 (19.7%) 55,076 (8.7%) 2.27 (1.91 – 2.70) 1.40 (1.15 – 1.70) 
Labour onset     
Spontaneous 201 (38.7%) 369,583 (58.1%) Ref Ref 
Planned delivery 316 (60.9%) 266,010 (41.8%) 1.46 (1.36 – 1.56) 1.15 (1.07 -1.23) 
Type of delivery     
Vaginal 299 (57.6%) 449,052 (70.6%) Ref Ref 
Caesarean 217 (41.8%) 186,411 (29.3%) 1.43 (1.30 – 1.59) 1.06 (0.96 – 1.17) 
Preterm birth (≤36 
weeks) 
75 (14.5%) 43,812 (6.9%) 2.10 (1.70 – 2.58) 1.50 (1.21 – 1.84) 
Spontaneous 22 (11.0%) 24,718 (6.7%) 1.63 (1.10 – 2.42) 1.26 (0.84 – 1.88) 
Planned 52 (16.5%) 19,087 (7.2%) 2.29 (1.78 – 2.94) 1.61 (1.25 – 2.06) 
Low Apgar at 5 
minutes (<7) 
24 (4.6%) 15,358 (2.4%) 1.91 (1.29 – 2.83) 1.60 (1.07 – 2.38) 
Preterm 11 (14.7%) 6,188 (14.1%) 1.04 (0.60 – 1.80) 1.11 (0.64 – 1.92) 
Term 13 (2.9%) 9,170 (1.6%) 1.89 (1.11 – 3.23) 1.65 (0.96 – 2.82) 
NICU/SCN 
admission 
145 (27.9%) 101,906 (16.0%) 1.74 (1.52 – 2.00) 1.26 (1.11 – 1.44) 
Preterm 55 (73.3%) 30,128 (68.6%) 1.07 (0.93 – 1.23) 0.99 (0.87 – 1.13) 
Term 90 (20.3%) 71,778 (12.1%) 1.67 (1.40 – 2.01) 1.26 (1.06 – 1.48) 
Perinatal death 10 (1.9%) 5,617 (0.9%) 2.18 (1.18 – 4.03) 1.73 (0.92 – 3.25) 
Small for 
gestational age 
43 (8.3%) 68,598 (10.8%) 0.77 (0.58 – 1.03) 0.81 (0.61 – 1.08) 
Large for 
gestational age 
79 (15.2%) 57,805 (9.1%) 1.68 (1.37 – 2.06) 1.27 (1.04 – 1.55) 
22 
RR = relative risk from Poisson regression models. CI = confidence interval. Adjusted models include the 
covariates of maternal age, country of birth, smoking, obesity, parity, socioeconomic disadvantage, chronic 
hypertension, pre-existing diabetes, gestational diabetes and pregnancy hypertension. Adjusted model for 
gestational diabetes only included the covariates of maternal age, country of birth, smoking, obesity, parity, 
and socioeconomic disadvantage. Adjusted model for pregnancy hypertension included these plus chronic 
hypertension and pre-existing diabetes. 
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Supplementary Table 1. ICD-10-AM codes used in the identification of sleep apnea. 
ICD-10-AM code Description Number of women (% of all 
cases in study) 
G47.30 Sleep apnoea, unspecified 170 (32.8%) 
G47.31 Central sleep apnoea syndrome 
(Central sleep hypopnoea syndrome) 
6 (1.2%) 
G47.32 Obstructive sleep apnoea syndrome 
(Obstructive sleep hypopnoea syndrome) 
336 (64.7%) 
G47.33 Sleep hypoventilation syndrome 1 (0.2%) 
G47.39 Other sleep apnoea 6 (1.2%) 
 Total 519 (100.0%) 
Note: ICD-10-AM refers to the Australian Modification of the ICD-10. These codes differ from 
those in the ICD-10.  
 
Supplementary Table 2. ICD-10-AM codes used in the identification of obesity. 
ICD-10-AM code Description Number of records (% of all 
records of obesity) 
E65 Localised adiposity 156 
E66.0 Obesity due to excess calories 12 
E66.1 Drug-induced obesity 1 
E66.2 Extreme obesity with alveolar 
hypoventilation 
None 
E66.8 Other obesity 
(Morbid obesity) 
1282 
E66.9 Obesity, unspecified 
(Simple obesity Not Otherwise Specified) 
2388 
 Total 3839 (100.0%) 
Note: There are 3 more obesity records than women with obesity (N=3836) because 2 women had 
both E65 and E66.9, and 1 woman had both E66.1 and E66.9. 
 
